Try our Advanced Search for more refined results
Life Sciences - August, 2010
172 articles
- Remand Bid Defeated In Propofol Class Action
- Prempro MDL Judge Nixes Plaintiffs' Expert Testimony
- Most Admired Attys: Skadden's Sheila Birnbaum
- KPMG Settles Accounting Fraud Class Action
- Ex-Pfizer Worker Loses Bid To Revive ERISA Dispute
- Baxter Fined $4.4M For Bundling IV Fluid Contracts
- J&J Unit Faces Suits Over Recalled Hip Implant
- In 3 Pa. Rulings, Pharma Loses A Little But Gains A Lot
- Medicare Part D Fraud Claims Preempted: 9th Circ.
- Most Admired Attys: Reed Smith's Michael Brown
- Jazz, Anchen Strike Deal Over Generic Luvox
- 2nd Circ. Nixes RxUSA's Bid To Revive Antitrust Suit
- Salix Settles With Novel Over Generic MoviPrep
- Eisai Wins Dismissal Of Apotex's Suit Over Aricept
- Trade Group Backs Matrixx On Side-Effect Reporting
- Avandia Probes Lead To ERISA Class Suit Against GSK
- Sanofi Hints At Hostile Bid After Genzyme Rejects Offer
- CVS Settles Mass. Drug Overcharge Claims For $2.7M
- MDL Judge Nixes Global Zicam Settlement
- Merck Faces Contract, IP Suit Over Dr. Scholl's Inserts
- Cooley Reps Bravo Health In $545M HealthSpring Buy
- Lilly Gets Longer Reprieve On Strattera Appeal
- Dentsply Loses Bid To Nab $4M In Contract Spat
- The Legal Market In Transition
- Most Admired Attys: Cooley's Anthony Stiegler
- Bayer, Bic Escape False Patent Marking Suits
- Ex-MoFo Partner Arrested For Bilking Schools, Insurers
- US, St. Jude In Talks To End Qui Tam Kickback Suit
- Sanofi Fails To Nix Approval For Generic Lovenox
- Novartis Cuts Patent From Suit Over Hemophilia Drugs
- LEO Pharma Fights Tolmar's Taclonex ANDA
- Stryker To Pay $1.4M Over Bone Protein Marketing
- Conn. Probes Rite Aid Over Discount Drug Price Hikes
- Export Council Gets Moving On US Trade Initiatives
- Rigel Shareholders Again Lose Suit Over Arthritis Drug
- Mexico OKs Mexichem-Cydsa Deal With Conditions
- AGA Says WL Gore Infringes Heart Device Patent
- Stryker To Snap Up Gaymar Industries For $150M
- Boniva ANDAs Infringe Roche Patent: Judge
- Blood Reagent Price-Fixing MDL Survives Dismissal Bid
- Sweat The Small Stuff — Nanotech Insurance Issues
- FDA Warns J&J Unit Over Joint Product Marketing
- 2nd Circ. Judge Hints At Antitrust Motive In RxUSA Suit
- Most Admired Attys: Durie Tangri's Mark Lemley
- Discovery To Proceed In Signalife Securities Action
- AstraZeneca UK Workers To Strike Over Pensions
- Biolitec Wins Partial Toss Of Medical Laser Patent Suit
- FDA Warns AMRI Over Contamination At Mass. Plant
- Schering Loses Round In Sunscreen Injunction Bid
- EVM Lobs Patent Suit At Boston Sci, Cordis, Abbott
- J&J Recalls Acuvue Lenses In Asia, Europe
- Most Admired Attys: WilmerHale's Bill Lee
- Schering Goes After Impax Over Vytorin ANDA
- DLA Piper Adds 6 Hogan Lovells IP Litigators In LA
- Pfizer Wants Dozens Tossed From Bextra MDL
- Cephalon Sues Apotex To Block Generic Nuvigil
- Wockhardt Exits Sepracor's Lunesta Patent Suit
- Zicam Maker Settles 18 Economic Injury Suits
- Mirapex Compulsive Gambling Suits To Remain MDL
- Premier's Arbitration Bid Nixed In Rival's Antitrust Suit
- Mylan Violated Mirapex Patent, Judge Rules
- Lilly Wins Short Ban On Generic Strattera
- Blank Rome Out As Counsel In Contract Suit V. J&J Unit
- Aurobindo, Torrent Infringe Sanofi's Uroxatral IP: Judge
- Understanding NC V. Tennessee Valley Authority
- Novartis Fights Alexion's Soliris Patent
- Prempro Plaintiffs Eye New Trial After Wyeth Win
- Inequitable Conduct Pleadings, Post-Exergen
- 6th Circ. Partially Revives Wyeth Redux Liability Suit
- 8th Circ. Nixes Hospital Antitrust Suit Against CR Bard
- Perrigo Sued Over ANDA For Psoriasis Shampoo
- Novartis Inks $670M Deal For Kidney Treatment Drug
- Most Admired Attys: Covington's Deborah Garza
- FDA, Rising? Oversight May Increase for Devices, Drugs
- Schering Shareholders Win Access To Board Notes
- Conceptus, Hologic Nix Non-IP Claims In Patent Spat
- Sanofi Wants FDA Approval Of Generic Lovenox Nixed
- Pa. Court Refuses To Nix Counsel In Risperdal Suit
- Watson CEO Must Face FTC Subpoena: Judge
- HealthGrades Faces Shareholder Suit Over Vestar Deal
- Watson Hit With False Marking Suit Over Androderm
- Aspen Snaps Up Sigma Pharma Unit In $816M Deal
- Corporate Piracy Efforts: Cost Center Or Profit Center?
- Lilly Seeks To Block Generic Strattera Amid Appeal
- FDA Threatens To Pull Blood Pressure Drug
- FTC Asks Novartis To Shed Drug For Alcon Deal
- Fried Frank, Howrey Rep Medco In $730M UBC Deal
- Roche Prevails In HPV-Test License Spat
- Most Admired Attys: McKool Smith's Sam Baxter
- Arguments Against Fixed Fees, And Why They're Myths
- KeyCorp ERISA Stock-Drop Class Action Nixed
- Biopsy Tool Patent Not Infringed: Fed. Circ.
- Bayer Faces False Marking Suit Over Glucose Monitors
- Plaintiffs' Atty Barred From Using Leaked Zyprexa Docs
- Pfizer Targets Actavis Over Generic Lipitor
- GSK Epilepsy, Bipolar Drug Linked To Meningitis
- Lilly's Patent For ADHD Drug Strattera Found Invalid
- Ex-St. Jude Exec Can't Work At Medtronic Until Nov.
- Study Contests Savings From Pay-For-Delay Bill
- Infringement Claims Nixed In VNUS Vein Treatment Suit
- 7th Circ. Sides With McNeil In $3.5M Motrin Allergy Case
- CardioNet Wins Dismissal Of Investor Class Action
- A Snapshot Of International Antitrust Developments
- J&J Faces Inquiries From State AGs Over Recalls
- Challenging CT Scans In Medical Monitoring Claims
- FDA Warns CorePharma Over Manufacturing Issues
- K&L Gates Nabs IP Corporate Partner From Foley
- Sanofi Fails To Shake Eisai's Lovenox Antitrust Suit
- Bard Hits Atrium, Endologix With Graft Patent Suit
- Novacare Recalls Supplements With ED Drug
- Ikaria Recalls Inomax DS Drug Delivery Systems
- Alphatec Hit With Securities Suit Over French Buy
- Conceptus Falsely Marked Sterilization Kit, Rival Says
- 3rd Circ. Revives Blueberry Farmers' Suit V. Novartis
- Patients Seek Cash From Troutman, Nursing Home Spat
- Feds Eyeing SciClone For Possible FCPA Violations
- AstraZeneca To Pay $198M To End Seroquel Suits
- FTC May Have Spilled Watson's Secrets, CEO Says
- Lupin Unit Sues Ranbaxy Over Antara ANDA
- Intervet Plan For Quiet Vetsulin Settlements Thwarted
- Is It Time For 'Total Recall' Of Medical Products?
- Skadden Advises Endo In $168M Penwest Buy
- EU OKs Novartis-Alcon Deal Following Sale Of Assets
- Best Medical Sues Ex-Workers, Accuray Over Patent
- Feds Intervene In St. Jude Kickback Suit
- FDA Warns Doctors Of Retrievable IVC Filter Risks
- FDA Blasts Novartis Over Drug Info On Facebook
- Teva Avoids Injunction In Alcon's Vigamox IP Suit
- Canada Clears Novartis-Alcon Deal With Divestitures
- Novo Wins Sex Harassment Suit Before 11th Circ.
- DLA Piper Names 2 Chairs To Succeed Leadership
- SEC, DOJ Launch FCPA Probe Into Merck
- FDA Could Warn Gilead For Manufacturing Issues
- Glenmark Settles Lunesta Patent Spat With Sepracor
- FTC Seeks More Info On $3.4B Grifols-Talecris Deal
- An Overview Of Section 337 Litigation Before The ITC
- Feds Want In On St. Jude Kickback Scheme Suit
- Invacare Hits Rival With 337 Suit Over Medical Beds
- $10M Verdict For Accutane User Nixed On Appeal
- Ex-Bristol-Myers Employee's Title VII Suit Revived
- Congress Urges FDA To Seek Sizable Budget Boost
- Bayer Wins Toss Of Third-Party Payors Suit In Yaz MDL
- Fed. Circ. Vacates Perrigo Win In Mucinex ANDA Spat
- Judge Won't Invalidate VNUS Laser Treatment Patents
- Fed. Circ. Revives Pig Virus Patent Claims V. Intervet
- Weight-Loss Pill Fraud Class Action Eighty-Sixed
- Daiichi, Apotex Settle Patent Suit Over Evoxac ANDA
- Sanofi's $24.2M Sex Bias Settlement Approved
- MDCO Wins 2nd Suit Over Angiomax Patent Extension
- Patent Examiner Interviews Post-Bilski
- Tiny Particles, Big Coverage Issues?
- Fed. Circ. Says Cordis Didn't Infringe Stent Patents
- Cuomo Probes Predatory Health Care Lending Claims
- FCBA Weighs In On Recusal In Myriad Gene Patent Suit
- AstraZeneca Puts 4K Seroquel Injury Claims To Bed
- EU OKs $4.9B Teva-Ratiopharm Deal, With Caveats
- Squire Sanders Adds 2 Life Sciences Gurus
- New Trial Ordered In $4M Wyeth Retaliation Suit
- FDA Looks To Streamline Device Approval Process
- 3rd Circ. Upholds Cyberonics Win In Liability Case
- Eisai Calls For Tough Inequitable Conduct Standard
- Wal-Mart, J&J Get Baby Shampoo Class Suits Tossed
- Employer, Beware: Outside Sales Reps May Require OT
- 11th Circ. Nixes Bio-Med Receiver's Bid To Clear Name
- Fed. Circ. Rebuffs Attack On Skelaxin Invalidity Ruling
- GSK Sets Up Fund To Resolve Poligrip Suits
- Sidley Austin Adds Ex-FDA Deputy Chief Counsel
- Edwards Angell Lures Morgan Lewis IP Partner
- Pfizer Win In Vaccine-Related Cancer Suit Overturned
- What's Causing The Rise In Pregnancy Bias Claims
- Ineos To Sell Films Business To Bilcare For €100M
- The Genomics And Personalized Medicine Act Of 2010